Mehri S. Mckellar
Expertise in
4
conditions

Dr. Mehri S. Mckellar

Infectious Disease
40 Duke Medicine Cir, 
Durham, NC 
On Staff At
Offers Telehealth
26 Years of Experience
Expertise in
4
conditions
40 Duke Medicine Cir, 
Durham, NC 

Overview

I am an infectious diseases physician with a focus on persons who have HIV. One of my major clinical and research interests is HIV prevention, such as rapid HIV testing and prevention through pre-exposure prophylaxis or PrEP in which people can take one pill per day to prevent HIV. I serve as the Medical Director of the Duke PrEP Clinic and have a number of projects in the community involving PrEP, including with populations who are difficult to reach. I am originally from Arizona, and love to hike, ski, and spend time with my family and friends.

Dr. Mckellar is highly rated in 4 conditions, according to our data. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Arizona College Of Medicine|, 2000

Specialties

Infectious Disease

Licenses

Internal Medicine in CA

Board Certifications

American Board Of Internal Med, Infectious Diseases

Fellowships

Infectious Diseases, University of Utah Medical Center

Hospital Affiliations

Duke University Hospital

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Duke Infectious Diseases Clinic - Clinic 1K
40 Duke Medicine Cir, Durham, NC 27710

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Biological
Study Drug: GSK3810109A
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
Providing A Resource: Telemedicine at Needle Exchanges to Reach Under-served Populations - Greensboro
Providing A Resource: Telemedicine at Needle Exchanges to Reach Under-served Populations - Greensboro
Enrollment Status: Completed
Publish Date: April 27, 2023
Intervention Type: Drug
Study Drugs: Suboxone, Truvada, Mavyret
Study Phase: Not Applicable
IGHID 11417 - The Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: Impact on the Latent HIV Reservoir and Long-Term Immunologic Effect
IGHID 11417 - The Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: Impact on the Latent HIV Reservoir and Long-Term Immunologic Effect
Enrollment Status: Completed
Publish Date: November 22, 2021
Intervention Type: Drug
Study Phase: Not Applicable
View 4 Less Clinical Trials

47 Total Publications

Preexposure Prophylaxis to Prevent HIV Acquisition: Perceptions among Sexual and Gender Minority Individuals in North Carolina.
Preexposure Prophylaxis to Prevent HIV Acquisition: Perceptions among Sexual and Gender Minority Individuals in North Carolina.
Journal: Southern medical journal
Published: July 15, 2025
Similar Doctors
John Crump
Expertise in
12
conditions
Dr. John Crump
Infectious Disease
Expertise in
12
conditions
Dr. John Crump
Infectious Disease

Private Diagnostic Clinic PLLC

2100 Erwin Rd, 
Durham, NC 
 (0.2 miles away)
919-684-8111
Languages Spoken:
English

John Crump is an Infectious Disease provider in Durham, North Carolina. Dr. Crump is highly rated in 12 conditions, according to our data. His top areas of expertise are Salmonella Enterocolitis, Typhoid Fever, Leptospirosis, and Sepsis.

Joseph Eron
Expertise in
8
conditions
Dr. Joseph Eron
Infectious Disease
Expertise in
8
conditions
Dr. Joseph Eron
Infectious Disease

UNC Hospitals Pulmonary Function Lab

101 Manning Dr, 
Chapel Hill, NC 
 (9.6 miles away)
984-974-7198
Languages Spoken:
English
See accepted insurances

Joseph Eron is an Infectious Disease provider in Chapel Hill, North Carolina. Dr. Eron is highly rated in 8 conditions, according to our data. His top areas of expertise are HIV/AIDS, AIDS Dysmorphic Syndrome, AIDS Dementia Complex, Myelitis, and Tissue Biopsy.

Joseph Tucker
Expertise in
10
conditions
Dr. Joseph Tucker
Infectious Disease
Expertise in
10
conditions
Dr. Joseph Tucker
Infectious Disease

Office

130 Mason Farm Rd, 
Chapel Hill, NC 
 (9.8 miles away)
919-966-2536
Languages Spoken:
English
See accepted insurances

Joseph Tucker is an Infectious Disease provider in Chapel Hill, North Carolina. Dr. Tucker is highly rated in 10 conditions, according to our data. His top areas of expertise are Syphilis, HIV/AIDS, Gonorrhea, and COVID-19.

Frequently Asked Questions about Dr. Mehri S. Mckellar

How do I make an appointment with Dr. Mehri S. Mckellar?

You can book an appointment with Dr. Mehri S. Mckellar by calling their office at 919-668-3197. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mehri S. Mckellar a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mehri S. Mckellar is classified as an Distinguished expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mehri S. Mckellar specialize in?

While Dr. Mehri S. Mckellar is a Infectious Disease, they have specific expertise in HIV/AIDS, Myelitis, and AIDS Dysmorphic Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Mehri S. Mckellar participate in research or clinical trials?

Yes. Dr. Mehri S. Mckellar has published 47 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Mehri S. Mckellar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mehri S. Mckellar accept my insurance?

Dr. Mehri S. Mckellar accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 919-668-3197 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mckellar's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile